|
|
|
ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$798.00 |
|
|
|
UBRELVY Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
|
VEMLIDY Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
|
VIZIMPRO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
|
UREA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
|
ANHYDROUS TRISODIUM CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
|
AMMONIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|